| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.25 | 0.1 |